Raghd is an Associate Partner of Syncona Investment Management Ltd, and currently Head of Strategy and Operations at Kesmalea Therapeutics.
Previously, Raghd was a core member of the healthcare practice at the Boston Consulting Group, with a particular focus on strategy and digital areas across Pharma, Biotech and Global Health sectors. Prior to BCG, Raghd completed a multidisciplinary PhD at the Wellcome Sanger Institute & University of Cambridge, bridging the fields of computational genomics, cancer and infectious disease.
Syncona portfolio companies
- Kesmalea Therapeutics (Board Observer)
- Clade Therapeutics